Annual SG&A
$603.77 M
+$33.02 M+5.79%
31 December 2023
Summary:
BioNTech SE annual selling, general & administrative expenses is currently $603.77 million, with the most recent change of +$33.02 million (+5.79%) on 31 December 2023. During the last 3 years, it has risen by +$479.86 million (+387.27%). BNTX annual SG&A is now at all-time high.BNTX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$165.52 M
-$32.39 M-16.36%
01 September 2024
Summary:
BioNTech SE quarterly selling, general & administrative expenses is currently $165.52 million, with the most recent change of -$32.39 million (-16.36%) on 01 September 2024. Over the past year, it has dropped by -$1.61 million (-0.96%). BNTX quarterly SG&A is now -16.36% below its all-time high of $197.91 million, reached on 30 June 2024.BNTX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$83.87 B
+$605.95 M+0.73%
01 September 2024
Summary:
BioNTech SE TTM selling, general & administrative expenses is currently $83.87 billion, with the most recent change of +$605.95 million (+0.73%) on 01 September 2024. Over the past year, it has increased by +$83.27 billion (+13902.90%). BNTX TTM SG&A is now -0.36% below its all-time high of $662.31 million, reached on 30 June 2024.BNTX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNTX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.8% | -1.0% | +10000.0% |
| 3 y3 years | +387.3% | +78.4% | +10000.0% |
| 5 y5 years | +1789.2% | +1223.0% | +10000.0% |
BNTX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +387.3% | -16.4% | +78.4% | -0.4% | +581.8% |
| 5 y | 5 years | at high | +1789.2% | -16.4% | +2062.9% | -0.4% | +3350.7% |
| alltime | all time | at high | +1789.2% | -16.4% | +2062.9% | -0.4% | +3350.7% |
BioNTech SE Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $165.52 M(-16.4%) | $660.70 M(-0.2%) |
| June 2024 | - | $197.91 M(+37.4%) | $662.31 M(+7.7%) |
| Mar 2024 | - | $144.03 M(-6.0%) | $614.77 M(+1.8%) |
| Dec 2023 | $603.77 M(+5.8%) | $153.24 M(-8.3%) | $603.92 M(+0.8%) |
| Sept 2023 | - | $167.13 M(+11.1%) | $598.95 M(+2.9%) |
| June 2023 | - | $150.37 M(+12.9%) | $582.12 M(-0.6%) |
| Mar 2023 | - | $133.18 M(-10.2%) | $585.66 M(+2.7%) |
| Dec 2022 | $570.75 M(+47.4%) | $148.27 M(-1.4%) | $570.42 M(-2.0%) |
| Sept 2022 | - | $150.30 M(-2.3%) | $582.04 M(+11.0%) |
| June 2022 | - | $153.92 M(+30.5%) | $524.53 M(+18.1%) |
| Mar 2022 | - | $117.93 M(-26.2%) | $444.25 M(+15.8%) |
| Dec 2021 | $387.14 M | $159.89 M(+72.3%) | $383.68 M(+37.4%) |
| Sept 2021 | - | $92.79 M(+26.0%) | $279.23 M(+28.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | $73.64 M(+28.4%) | $217.54 M(+30.9%) |
| Mar 2021 | - | $57.36 M(+3.5%) | $166.15 M(+31.1%) |
| Dec 2020 | $123.91 M(+155.6%) | $55.44 M(+78.2%) | $126.78 M(+60.5%) |
| Sept 2020 | - | $31.11 M(+39.8%) | $78.99 M(+30.8%) |
| June 2020 | - | $22.25 M(+23.7%) | $60.40 M(+12.7%) |
| Mar 2020 | - | $17.99 M(+135.1%) | $53.59 M(+17.3%) |
| Dec 2019 | $48.47 M(+51.7%) | $7.65 M(-38.8%) | $45.67 M(-5.1%) |
| Sept 2019 | - | $12.51 M(-19.0%) | $48.13 M(+9.0%) |
| June 2019 | - | $15.44 M(+53.3%) | $44.14 M(+53.8%) |
| Mar 2019 | - | $10.07 M(-0.4%) | $28.70 M(+54.1%) |
| Dec 2018 | $31.96 M(-4.3%) | $10.11 M(+18.6%) | $18.63 M(+118.6%) |
| Sept 2018 | - | $8.52 M | $8.52 M |
| Dec 2017 | $33.40 M | - | - |
FAQ
- What is BioNTech SE annual selling, general & administrative expenses?
- What is the all time high annual SG&A for BioNTech SE?
- What is BioNTech SE annual SG&A year-on-year change?
- What is BioNTech SE quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for BioNTech SE?
- What is BioNTech SE quarterly SG&A year-on-year change?
- What is BioNTech SE TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for BioNTech SE?
- What is BioNTech SE TTM SG&A year-on-year change?
What is BioNTech SE annual selling, general & administrative expenses?
The current annual SG&A of BNTX is $603.77 M
What is the all time high annual SG&A for BioNTech SE?
BioNTech SE all-time high annual selling, general & administrative expenses is $603.77 M
What is BioNTech SE annual SG&A year-on-year change?
Over the past year, BNTX annual selling, general & administrative expenses has changed by +$33.02 M (+5.79%)
What is BioNTech SE quarterly selling, general & administrative expenses?
The current quarterly SG&A of BNTX is $165.52 M
What is the all time high quarterly SG&A for BioNTech SE?
BioNTech SE all-time high quarterly selling, general & administrative expenses is $197.91 M
What is BioNTech SE quarterly SG&A year-on-year change?
Over the past year, BNTX quarterly selling, general & administrative expenses has changed by -$1.61 M (-0.96%)
What is BioNTech SE TTM selling, general & administrative expenses?
The current TTM SG&A of BNTX is $83.87 B
What is the all time high TTM SG&A for BioNTech SE?
BioNTech SE all-time high TTM selling, general & administrative expenses is $662.31 M
What is BioNTech SE TTM SG&A year-on-year change?
Over the past year, BNTX TTM selling, general & administrative expenses has changed by +$83.27 B (+13902.90%)